Evidence map›Paper›PMID 26188287›Full record

ReviewProgress in neuro-psychopharmacology & biological psychiatry2016

The role of the gut-brain axis in alcohol use disorders.

Jonathan Gorky, James Schwaber

Open access · greenAbstract readReview
In one paragraph

Review in Progress in neuro-psychopharmacology & biological psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Novel medications for problematic alcohol use.The Journal of clinical investigation · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jonathan GorkyDaniel Baugh Institute for Functional Genomics and Computational Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
James SchwaberDaniel Baugh Institute for Functional Genomics and Computational Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: james.schwaber@jefferson.edu.
Thomas Jefferson University · US

Funding

Alcohol Tissue InjuryT32AA007463 · NIAAA · THOMAS JEFFERSON UNIVERSITY · PI HOEK, JOANNES B, VADIGEPALLI, RAJANIKANTH · 1985 to 2021
$9.1M
Modeling Central Autonomic Regulatory Network Adaptation to HypertensionR01HL111621 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SCHWABER, JAMES, VADIGEPALLI, RAJANIKANTH · 2012 to 2015
$2.4M
Integrated Modeling of Adaptive Neuronal RegulationR01GM083108 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI SCHWABER, JAMES, VADIGEPALLI, RAJANIKANTH · 2009 to 2012
$1.5M
Neuroimmune Cell Networks in Opioid Dependence and WithdrawalR21DA036372 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI SCHWABER, JAMES · 2013 to 2014
$388k
NHLBI NIH HHS R01 HL111621NHLBI NIH HHS R01 HL111621-01A1NIAAA NIH HHS T32 AA007463NIAAA NIH HHS T32 AA007463-28NIDA NIH HHS R21 DA036372NIDA NIH HHS R21 DA036372-01NIGMS NIH HHS R01 GM083108
6 · The paper itself

Abstract

Neuroimmune and inflammatory processes have been locally associated with the amygdala in alcohol exposure and withdrawal. We and others have suggested that this inflammation in the amygdala may cause disturbance of neural function observed as anxiety and autonomic distress in withdrawal. Despite the potential importance of the robust neuroinflammatory response, the mechanisms contributing to this response are not well understood. We review literature that suggests the effects of alcohol, and other substances of abuse, cause dysbiosis of the gut microbiome. This peripheral response may modulate neuroprotective vagal afferent signaling that permits and exacerbates a neuroinflammatory response in the amygdala. We will examine the mounting evidence that suggests that (1) gut dysbiosis contributes to neuroinflammation, especially in the context of alcohol exposure and withdrawal, (2) the neuroinflammation in the amygdala involves the microglia and astrocytes and their effect on neural cells, and (3) amygdala neuroinflammation itself contributes directly to withdrawal behavior and symptoms. The contribution of the gut to an anxiogenic response is a promising therapeutic target for patients suffering with withdrawal symptoms given the safe and well-established methods of modulating the gut microbiome.

Indexed as

Alcohol-Related DisordersAnimalsBrainGastrointestinal MicrobiomeHumansNeuroimmunomodulationGut–brain axisGut microbiomeNeuroinflammationVagus nerveWithdrawal

Identifiers

PMID26188287
PMCPMC4679635
OpenAlexW887189684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.